TNYA
Tenaya Therapeutics, Inc.$0.84-0.02 (-2.60%)Prev Close$0.86·MCap$125.7M·P/E—·Vol1.70M·Yield—
▲
Buys (12M)
0
$0.00
▼
Sells (12M)
15
$5.07M
◆
Net Activity
Net Seller
$5.07M
●
Active Insiders
4
last 12 mo
Over the past 12 months, insider activity at Tenaya Therapeutics, Inc. (TNYA) has been exclusively selling, with 0 insider purchases totaling $0.00 and 15 insider sales totaling $5.07M. The most recent insider transaction was by Tingley Whittemore (officer: Chief Medical Officer), who sold $2.5K worth of shares on May 19, 2026. Tenaya Therapeutics, Inc. operates in the Healthcare sector, within the Biotechnology industry, with a market cap of $125.7M.
TNYA Insider Trading Activity
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| May 19, 2026 | Tingley Whittemore | officer: Chief Medical Officer | Sell | 3,121 | $0.79 | $2.5K | 215,497 |
| May 19, 2026 | Higa Tomohiro | officer: SVP, Finance | Sell | 1,485 | $0.79 | $1.2K | 118,267 |
| May 19, 2026 | Ali Faraz | director, officer: Chief Executive Officer | Sell | 3,390 | $0.79 | $2.7K | 440,014 |
| Feb 26, 2026 | COLUMN GROUP III GP, LP | 10 percent owner | Sell | 2,520,985 | $0.58 | $1.45M1.5% OS | 1,862,545-58% |
| Feb 24, 2026 | COLUMN GROUP III GP, LP | 10 percent owner | Sell | 829,734 | $0.61 | $504.8K | 2,374,048-26% |
| Feb 17, 2026 | Ali Faraz | director, officer: Chief Executive Officer | Sell | 29,724 | $0.64 | $19.1K | 452,415 |
| Feb 17, 2026 | Tingley Whittemore | officer: Chief Medical Officer | Sell | 7,036 | $0.64 | $4.5K | 220,494 |
| Feb 17, 2026 | Higa Tomohiro | SVP, Finance | Sell | 6,938 | $0.64 | $4.5K | 122,610 |
| Feb 12, 2026 | COLUMN GROUP III GP, LP | 10 percent owner | Sell | 4,400,290 | $0.69 | $3.04M2.6% OS | 4,803,275-48% |
| Nov 17, 2025 | Ali Faraz | Chief Executive Officer | Sell | 3,126 | $1.33 | $4.2K | 299,666 |
| Nov 17, 2025 | Higa Tomohiro | SVP, Finance | Sell | 1,367 | $1.33 | $1.8K | 93,971 |
| Nov 17, 2025 | Tingley Whittemore | Chief Medical Officer | Sell | 2,877 | $1.33 | $3.8K | 169,926 |
| Aug 18, 2025 | Ali Faraz | Chief Executive Officer | Sell | 14,533 | $1.25 | $18.2K | 311,605 |
| Aug 18, 2025 | Higa Tomohiro | SVP, Finance | Sell | 2,962 | $1.25 | $3.7K | 97,777 |
| Aug 18, 2025 | Tingley Whittemore | Chief Medical Officer | Sell | 3,445 | $1.25 | $4.3K | 176,248 |
| May 16, 2025 | Ali Faraz | Chief Executive Officer | Sell | 3,189 | $0.44 | $1.4K | 317,325 |
| May 16, 2025 | Higa Tomohiro | SVP, Finance | Sell | 1,390 | $0.44 | $615.35 | 98,300 |
| May 16, 2025 | Tingley Whittemore | Chief Medical Officer | Sell | 2,937 | $0.44 | $1.3K | 171,856 |
| Mar 10, 2025 | Ali Faraz | Chief Executive Officer | Sell | 9,741 | $0.54 | $5.2K | 324,461 |
| Mar 10, 2025 | Higa Tomohiro | SVP, Finance | Sell | 2,482 | $0.54 | $1.3K | 101,155 |
| Mar 10, 2025 | Tingley Whittemore | Chief Medical Officer | Sell | 7,398 | $0.54 | $4.0K | 180,464 |
| Mar 7, 2025 | COLUMN GROUP III GP, LP | Buy | 35,714,284 | $0.70 | $25.00M21.4% OS | 49,313,560+263% | |
| Nov 18, 2024 | Saito Chihiro | SVP, Accounting and Fin. Ops. | Sell | 2,258 | $2.12 | $4.8K | 60,983 |
| Aug 19, 2024 | Saito Chihiro | SVP, Accounting and Fin. Ops. | Sell | 2,363 | $2.89 | $6.8K | 64,702 |
| Aug 16, 2024 | Ali Faraz | Chief Executive Officer | Sell | 9,748 | $2.89 | $28.2K | 192,277 |
| Aug 16, 2024 | Tingley Whittemore | Chief Medical Officer | Sell | 7,428 | $2.89 | $21.5K | 108,731 |
| Mar 6, 2024 | Hoey Timothy | Chief Scientific Officer | Sell | 3,300 | $7.00 | $23.1K | 245,346 |
| Feb 21, 2024 | Hoey Timothy | Chief Scientific Officer | Sell | 6,569 | $5.34 | $35.0K | 236,346 |
| Feb 16, 2024 | Ali Faraz | Chief Executive Officer | Sell | 6,358 | $5.86 | $37.3K | 113,079 |
| Feb 16, 2024 | Hoey Timothy | Chief Scientific Officer | Sell | 4,681 | $5.86 | $27.4K | 242,715 |
| Feb 16, 2024 | PATTERSON LEONE D | Chief Fin. and Bus. Officer | Sell | 5,201 | $5.86 | $30.5K | 60,755 |
| Feb 16, 2024 | Tingley Whittemore | Chief Medical Officer | Sell | 6,500 | $5.86 | $38.1K | 73,534 |
| Feb 14, 2024 | COLUMN GROUP III GP, LP | Buy | 2,222,222 | $4.50 | $10.00M1.3% OS | 13,599,275 | |
| Aug 29, 2023 | Hoey Timothy | Chief Scientific Officer | Sell | 7,243 | $4.26 | $30.9K | 247,396 |
| Aug 18, 2023 | Ali Faraz | Chief Executive Officer | Sell | 5,563 | $3.81 | $21.2K | 119,437 |
| Aug 18, 2023 | Hoey Timothy | Chief Scientific Officer | Sell | 4,007 | $3.81 | $15.3K | 254,639 |
| Aug 18, 2023 | PATTERSON LEONE D | Chief Fin. and Bus. Officer | Sell | 4,452 | $3.81 | $17.0K | 64,542 |
| Aug 18, 2023 | Tingley Whittemore | Chief Medical Officer | Sell | 5,563 | $3.81 | $21.2K | 76,437 |
| Mar 14, 2023 | COLUMN GROUP III GP, LP | 10% Owner | Buy | 6,779 | $2.60 | $17.6K | 11,377,053 |
| Feb 10, 2023 | COLUMN GROUP III GP, LP | 10% Owner | Buy | 1,500,000 | $2.60 | $3.90M0.9% OS | 11,370,274 |
| Jan 23, 2023 | COLUMN GROUP III GP, LP | 10% Owner | Buy | 69,739 | $2.50 | $174.2K | 9,870,274 |
| Jan 19, 2023 | COLUMN GROUP III GP, LP | 10% Owner | Buy | 185,151 | $2.51 | $464.8K | 9,800,535 |
| Dec 9, 2022 | Srivastava Deepak | Director | Buy | 230,769 | $2.60 | $600.0K | 372,435+163% |
| Nov 25, 2022 | Casdin Eli | Director | Buy | 2,492,042 | $2.60 | $6.48M1.5% OS | 6,078,860+69% |
| Nov 23, 2022 | COLUMN GROUP III GP, LP | 10% Owner | Buy | 9,615,384 | $2.60 | $25.00M5.8% OS | 9,615,384 |
| Apr 28, 2022 | Hoey Timothy | Chief Scientific Officer | Sell | 1,353 | $10.13 | $13.7K | 198,646 |
| Aug 4, 2021 | Casdin Partners Master Fund, L.P. | 10% Owner | Buy | 850,000 | $15.00 | $12.75M0.5% OS | 3,224,849+36% |
TNYA Insider Buying Activity
The following table shows recent insider purchases of Tenaya Therapeutics, Inc. (TNYA) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Mar 7, 2025 | COLUMN GROUP III GP, LP | Buy | 35,714,284 | $0.70 | $25.00M21.4% OS | 49,313,560+263% | |
| Feb 14, 2024 | COLUMN GROUP III GP, LP | Buy | 2,222,222 | $4.50 | $10.00M1.3% OS | 13,599,275 | |
| Mar 14, 2023 | COLUMN GROUP III GP, LP | 10% Owner | Buy | 6,779 | $2.60 | $17.6K | 11,377,053 |
| Feb 10, 2023 | COLUMN GROUP III GP, LP | 10% Owner | Buy | 1,500,000 | $2.60 | $3.90M0.9% OS | 11,370,274 |
| Jan 23, 2023 | COLUMN GROUP III GP, LP | 10% Owner | Buy | 69,739 | $2.50 | $174.2K | 9,870,274 |
| Jan 19, 2023 | COLUMN GROUP III GP, LP | 10% Owner | Buy | 185,151 | $2.51 | $464.8K | 9,800,535 |
| Dec 9, 2022 | Srivastava Deepak | Director | Buy | 230,769 | $2.60 | $600.0K | 372,435+163% |
| Nov 25, 2022 | Casdin Eli | Director | Buy | 2,492,042 | $2.60 | $6.48M1.5% OS | 6,078,860+69% |
| Nov 23, 2022 | COLUMN GROUP III GP, LP | 10% Owner | Buy | 9,615,384 | $2.60 | $25.00M5.8% OS | 9,615,384 |
| Aug 4, 2021 | Casdin Partners Master Fund, L.P. | 10% Owner | Buy | 850,000 | $15.00 | $12.75M0.5% OS | 3,224,849+36% |
TNYA Insider Selling Activity
The following table shows recent insider sales of Tenaya Therapeutics, Inc. (TNYA) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| May 19, 2026 | Tingley Whittemore | officer: Chief Medical Officer | Sell | 3,121 | $0.79 | $2.5K | 215,497 |
| May 19, 2026 | Higa Tomohiro | officer: SVP, Finance | Sell | 1,485 | $0.79 | $1.2K | 118,267 |
| May 19, 2026 | Ali Faraz | director, officer: Chief Executive Officer | Sell | 3,390 | $0.79 | $2.7K | 440,014 |
| Feb 26, 2026 | COLUMN GROUP III GP, LP | 10 percent owner | Sell | 2,520,985 | $0.58 | $1.45M1.5% OS | 1,862,545-58% |
| Feb 24, 2026 | COLUMN GROUP III GP, LP | 10 percent owner | Sell | 829,734 | $0.61 | $504.8K | 2,374,048-26% |
| Feb 17, 2026 | Ali Faraz | director, officer: Chief Executive Officer | Sell | 29,724 | $0.64 | $19.1K | 452,415 |
| Feb 17, 2026 | Tingley Whittemore | officer: Chief Medical Officer | Sell | 7,036 | $0.64 | $4.5K | 220,494 |
| Feb 17, 2026 | Higa Tomohiro | SVP, Finance | Sell | 6,938 | $0.64 | $4.5K | 122,610 |
| Feb 12, 2026 | COLUMN GROUP III GP, LP | 10 percent owner | Sell | 4,400,290 | $0.69 | $3.04M2.6% OS | 4,803,275-48% |
| Nov 17, 2025 | Ali Faraz | Chief Executive Officer | Sell | 3,126 | $1.33 | $4.2K | 299,666 |
| Nov 17, 2025 | Higa Tomohiro | SVP, Finance | Sell | 1,367 | $1.33 | $1.8K | 93,971 |
| Nov 17, 2025 | Tingley Whittemore | Chief Medical Officer | Sell | 2,877 | $1.33 | $3.8K | 169,926 |
| Aug 18, 2025 | Ali Faraz | Chief Executive Officer | Sell | 14,533 | $1.25 | $18.2K | 311,605 |
| Aug 18, 2025 | Higa Tomohiro | SVP, Finance | Sell | 2,962 | $1.25 | $3.7K | 97,777 |
| Aug 18, 2025 | Tingley Whittemore | Chief Medical Officer | Sell | 3,445 | $1.25 | $4.3K | 176,248 |
| May 16, 2025 | Ali Faraz | Chief Executive Officer | Sell | 3,189 | $0.44 | $1.4K | 317,325 |
| May 16, 2025 | Higa Tomohiro | SVP, Finance | Sell | 1,390 | $0.44 | $615.35 | 98,300 |
| May 16, 2025 | Tingley Whittemore | Chief Medical Officer | Sell | 2,937 | $0.44 | $1.3K | 171,856 |
| Mar 10, 2025 | Ali Faraz | Chief Executive Officer | Sell | 9,741 | $0.54 | $5.2K | 324,461 |
| Mar 10, 2025 | Higa Tomohiro | SVP, Finance | Sell | 2,482 | $0.54 | $1.3K | 101,155 |
| Mar 10, 2025 | Tingley Whittemore | Chief Medical Officer | Sell | 7,398 | $0.54 | $4.0K | 180,464 |
| Nov 18, 2024 | Saito Chihiro | SVP, Accounting and Fin. Ops. | Sell | 2,258 | $2.12 | $4.8K | 60,983 |
| Aug 19, 2024 | Saito Chihiro | SVP, Accounting and Fin. Ops. | Sell | 2,363 | $2.89 | $6.8K | 64,702 |
| Aug 16, 2024 | Ali Faraz | Chief Executive Officer | Sell | 9,748 | $2.89 | $28.2K | 192,277 |
| Aug 16, 2024 | Tingley Whittemore | Chief Medical Officer | Sell | 7,428 | $2.89 | $21.5K | 108,731 |
| Mar 6, 2024 | Hoey Timothy | Chief Scientific Officer | Sell | 3,300 | $7.00 | $23.1K | 245,346 |
| Feb 21, 2024 | Hoey Timothy | Chief Scientific Officer | Sell | 6,569 | $5.34 | $35.0K | 236,346 |
| Feb 16, 2024 | Ali Faraz | Chief Executive Officer | Sell | 6,358 | $5.86 | $37.3K | 113,079 |
| Feb 16, 2024 | Hoey Timothy | Chief Scientific Officer | Sell | 4,681 | $5.86 | $27.4K | 242,715 |
| Feb 16, 2024 | PATTERSON LEONE D | Chief Fin. and Bus. Officer | Sell | 5,201 | $5.86 | $30.5K | 60,755 |
| Feb 16, 2024 | Tingley Whittemore | Chief Medical Officer | Sell | 6,500 | $5.86 | $38.1K | 73,534 |
| Aug 29, 2023 | Hoey Timothy | Chief Scientific Officer | Sell | 7,243 | $4.26 | $30.9K | 247,396 |
| Aug 18, 2023 | Ali Faraz | Chief Executive Officer | Sell | 5,563 | $3.81 | $21.2K | 119,437 |
| Aug 18, 2023 | Hoey Timothy | Chief Scientific Officer | Sell | 4,007 | $3.81 | $15.3K | 254,639 |
| Aug 18, 2023 | PATTERSON LEONE D | Chief Fin. and Bus. Officer | Sell | 4,452 | $3.81 | $17.0K | 64,542 |
| Aug 18, 2023 | Tingley Whittemore | Chief Medical Officer | Sell | 5,563 | $3.81 | $21.2K | 76,437 |
| Apr 28, 2022 | Hoey Timothy | Chief Scientific Officer | Sell | 1,353 | $10.13 | $13.7K | 198,646 |
TNYA Insiders
Similar Stocks to TNYA
VRTX
Vertex Pharmaceuticals Incorporated
$476.29+0.08%
$126.50B
REGN
Regeneron Pharmaceuticals, Inc.
$662.73+1.01%
$68.29B
ALNY
Alnylam Pharmaceuticals, Inc.
$275.93-1.72%
$43.19B
RVMD
Revolution Medicines, Inc.
$185.71+0.42%
$40.34B
MRNA
Moderna, Inc.
$68.11+1.00%
$27.09B
INSM
Insmed Incorporated
$109.25-0.67%
$25.06B
INCY
Incyte Corporation
$114.43-0.30%
$23.32B
UTHR
United Therapeutics Corporation
$530.63+0.75%
$23.22B